期刊文献+

左炔诺孕酮宫内缓释系统对功能失调性子宫出血治疗效果观察 被引量:5

Effect of the levonorgestrel-releasing intrauterine device ( Mirena ) in the treatment of dysfunctional uterine bleeding
原文传递
导出
摘要 目的观察左炔诺孕酮宫内缓释系统(LNG-IUS;商品名:曼月乐)对功能失调性子宫出血的临床疗效。方法对45例子宫内膜诊刮病理诊断为功能失调性子宫出血患者放置左炔诺孕酮宫内缓释系统,在放置前和放置满24个月内定期B超监测子宫内膜厚度,观察患者血红蛋白情况及月经改善情况。结果置LNG-IUS前子宫内膜厚度为(15.6±4.2)mm,置LNG-IUS24个月子宫内膜厚度为(3.2±1.3)mm,两者比较差异有统计学意义(U=2.82,P〈0.01);放置LNG—IUS6个月后患者血红蛋白显着升高[(97.6±8.2)g/L升到(123.7±8.1)g/L],差异有统计学意义(U=2.26,P〈0.05)。置LNG—IUS后患者出现不规则少量子宫出血或点滴出血。结论左炔诺孕酮宫内缓释系统不但能从临床方面有效地控制月经,对功血有持续的疗效,对复杂型增生的子宫内膜也有抑制作用。 Objective To evaluate the efficacy and side-effects of the levonorgestrel-releasing intrauterine device (Mirena) in the treatment of dysfunctional uterine bleeding . Methods 45 cases of dysfunctional uterine bleeding diagnosed by pathology were installed with Mirena. The endometrial thickness by uhrasound,hemoglobulin increase and pathologic changes of endometria were recorded before and 24 months after the installation. Results The endometrial thickness before and after the insertion of Mirena were( 15.6 ± 4. 2) mm and ( 3.2 ± 1.3 ) mmrespectively ( P 〈 0. 01 ). Six months after the insertion of Mirena, patients' hemoglobulin was significantly increased from ( 97. 6 ± 8.2 ) g/L to ( 123.7 ± 8.1 ) g/L ( U = 2. 26, P 〈 0. 05 ). After the installation of Mirena, patient experienced metrorrhagia. ConclusionsMirena is a device providing effective and continual therapy for dysfunctional uterine bleeding . It can not only significantly reduce the menstrual blood loss but also reverse the complex hyperplasia effectively.
出处 《中国综合临床》 2011年第9期993-995,共3页 Clinical Medicine of China
关键词 左炔诺孕酮宫内缓释系统 功能失调性子宫出血 子宫内膜 Levonorgestrel-releasing intrauterine device Dysfunctional uterine bleeding Endometrial hyperplasia
  • 相关文献

参考文献5

  • 1Tang GW,Lo SS.Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women:efficacy versus acceptability[J].Contraception,1995,51 (4) :231-235. 被引量:1
  • 2Pakarinen P,Luukkainen T.Treatment of menorrhagia with an LNG-IUS[J].Contraception,2007,75 (6 Suppl) :S118-122. 被引量:1
  • 3French R,Cowan F,Mansour D,et al.Hormonally impregnated intrauterine systems (IUSs),versus other forms of reversible contraceptives as effective methods of preventing pregnancy[J].Cochrane Database Syst Rev,2001,(2):CD001776. 被引量:1
  • 4Wildemeersch D,Janssens D,Schacht E,et al.Intrauterine levonorgestrel delivered by a frameless system,combined with systemic estrogen:acceptability and endometrial safety after 3 years of use in peri-and postmenopausal women [J].Gynecol Endocrinol,2005,20 (6) :336-342. 被引量:1
  • 5谢梅青,翁梅英,郭璇华,杨冬梓,邝健全,吴金浪.左炔诺孕酮宫内缓释系统治疗子宫内膜增生过长的疗效[J].中山医科大学学报,2002,23(4):291-294. 被引量:39

二级参考文献1

共引文献38

同被引文献39

  • 1刘冬娥.女性围绝经期的生理和病理变化[J].中国实用妇科与产科杂志,2004,20(8):473-474. 被引量:249
  • 2朱四军,赵白鸽,谢衷明.RU486对下丘脑-垂体-卵巢-子宫内膜轴的功能影响[J].生殖与避孕,1995,15(4):243-248. 被引量:299
  • 3刘冬娥 张帝开 李秀云等.青春期子宫出血54例临床分析.中国实用妇科与产科杂志,2010,:678-678. 被引量:2
  • 4何亚轩.医院妇(产)科手术创新操作与图谱详解及并发症防范处理实用全书[M].北京:中国知识出版社,2006:1149. 被引量:2
  • 5曹泽敏.中华妇产科学[M].北京:人民卫生出版社,1996:2121. 被引量:3
  • 6秦丽娜,刘银凤,马计唤.去氧孕烯炔雌醇片在人工流产术后的临床应用.中国医药,2012,7增刊:57-58. 被引量:2
  • 7程金华,张玉荣.妈富隆治疗子宫肌瘤52例临床观察.中国实用妇科与产科杂志,2009,19(11):4930. 被引量:1
  • 8Weisberg E, Hickey M, Palmer D, er al. A pilot study to assess theeffect of three short term treatment on frequent and/or prolonged bleeding compared to placdbo in women using Implanon. Hum Reprod ,2005,13 (10) :287-288. 被引量:1
  • 9Beatty MN, Blumnthal FD. The levonorgestrel-releasing intrauterine system : Safety, efficacy, and patient acceptability [J]. Ther Clin Risk Manag, 2009,5(3) :561-574. 被引量:1
  • 10Beatty MN, Blumnthal PD. The Levonorgestrel-releasing intrautering system : Safety, efficacy, and patient acceptability [ J ]. Ther Clin Risk Manag,2009,5 ( 3 ) :561-574. 被引量:1

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部